tiprankstipranks

David Hochman Insider Profile

4 Followers
David Hochman, Director at Corbus Pharmaceuticals, holds 693.00K shares in Orchestra BioMed Holdings (Ticker: OBIO), holds 2.47M shares in Motus Gi Holdings (Ticker: MOTS), holds 1.05M shares in Corbus Pharmaceuticals (Ticker: CRBP).
tipranks
David Hochman

David Hochman
Corbus Pharmaceuticals (CRBP)
Director

Ranked #85,116 out of 98,743 Corporate Insiders

Profitable Transactions

21%
4 out of 19 Profitable Transactions

Average Return

-13.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$44M
91.34%
8.17%
0.49%
A breakdown of David Hochman's holdings

Insider Roles

Corbus Pharmaceuticals
(CRBP)
Director
Orchestra BioMed Holdings
(OBIO)
CEO and Chairperson, Director
Motus Gi Holdings
(MOTS)
Director, Chairman of the Board
Roles that David Hochman holds in companies

Most Profitable Insider Trade

Stock:
Corbus Pharmaceuticals
(CRBP)
Rating:Informative Buy
Date:Aug 18, 2015 - Aug 18, 2016
Return:+94.00%
The most profitable trade made by David Hochman

David Hochman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Corbus Pharmaceuticals
Mar 18, 2019
Director
Informative Buy
13.94K
$40.60M
Motus Gi Holdings
Jan 07, 2022
Director, Chairman of the Board
Uninformative Buy
$219.81K
Orchestra BioMed Holdings
Jul 24, 2023
CEO and Chairperson, Director
Uninformative Buy
$3.63M
List of latest transactions for each holding click on a transaction to see David Hochman's performance on stock

David Hochman insider profile FAQ

What is the percentage of profitable transactions made by David Hochman?
The percentage of profitable transactions made by David Hochman is 21%.
    What is the average return per transaction made by David Hochman?
    The average return per transaction made by David Hochman is -13.50%.
      What stocks does David Hochman hold?
      David Hochman holds: CRBP, MOTS, OBIO stocks.
        What was David Hochman’s latest transaction?
        David Hochman latest transaction was an Uninformative Buy of ―.
          What was David Hochman's most profitable transaction?
          David Hochman’s most profitable transaction was an Informative Buy of CRBP stock on August 18, 2015. The return on the trade was 94.00%.
            What is David Hochman's role in Corbus Pharmaceuticals?
            David Hochman's role in Corbus Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.